Portfolio News
Sofinnova Capital
Nucana set to follow ‘groundbreaking’ ASCO data with phase III trial
Nucana set to follow ‘groundbreaking’ ASCO data with phase III trial
Nucana in the "BIOWORLDBWT06012015 (2) TODAY" June 1, 2015
Related News
Moon Surgical Expands Maestro® Platform into a Multi-Model Physical AI Platform with Software Version 2.7, Driving Automation Across the Surgical Workflow
Ingenix raises €13M led by Sofinnova to scale Modality Fusion AI
P2 Science raises $23M to expand green chemistry platform
HAYA Therapeutics doses first cohort in Phase 1 trial
Tulyp Medical appoints Steve Motes as CEO